You are viewing the site in preview mode

Skip to main content

Table 1 Demographic, clinical, imaging, and histological/oncological characteristics of SFC patients operated on by ERC, LC, and SLC

From: Emergency surgery for splenic flexure cancer: results of the SFC Study Group database

  Total sample (n = 90) ERC (n = 55) LC (n = 18) SLC (n = 17) P value
Demographic and clinical variables
 Gender (M/F) [n] 53/37 33/22 12/6 8/9 0.482
 Age (year) [median (range)] 71 (33-94) 73 (38-94) 61.5 (33-90.7) 74.7 (43-84.3) 0.044
 Age > 75 (year) [n (%)] 34 (37.8) 22 (40) 4 (22.2) 8 (47.1) 0.274
 BMI (kg/m2) [median (range)] 25.8 (14-34) 25.3 (14-34) 22 (17-32.3) 26.1 (21-34) 0.082
 Obesity (BMI ≥ 30 kg/m2) [n (%)] 16 (17.8) 10 (18.2) 2 (11.1) 4 (23.5) 0.626
 ASA score [n%]      0.043
  • I-II 42 (46.7) 21 (38.2) 13 (72.2) 8 (47.1)  
  • III-IV 48 (53.3) 34 (61.8) 5 (27.8) 9 (52.9)  
 Pre-operative leukocytes (109/L) [mean (SD)] 10.96 (4.73) 11.5 (5.21) 10.99 (3.60) 8.95 (3.48) 0.198
 Weight loss > 10% [n (%)] 25 (27.8) 16 (29.1) 6 (33.3) 3 (17.6) 0.550
 Pre-operative serum CEA (U/mL) [median (range)] 33.65 (0.4-275.5) 33.65 (1.10-244.7) 54.7 (0.4-275.5) 23 (1.4-92.9) 0.241
 Comorbidity (> 1) [n (%)] 38 (42.2) 25 (45.5) 6 (33.3) 7 (41.2) 0.662
 Diabetes [n (%)] 14 (15.6) 10 (18.2) 2 (11.1) 2 (11.8) 0.689
 Cardiopulmonary diseases [n (%)] 57 (63.3) 32 (58.2) 12 (66.7) 13 (76.5) 0.372
 Kidney failure [n (%)] 6 (6.7) 4 (7.3) 1 (5.6) 1 (5.9) 0.958
 Neurocognitive disorders [n (%)] 14 (15.6) 7 (12.7) 2 (11.1) 5 (29.4) 0.213
 Smoking [n (%)] 30 (33.3) 20 (36.4) 6 (33.3) 4 (23.5) 0.618
 Indication for surgery [n (%)]      0.451
  • Colonic obstruction 75 (83.3) 48 (87.3) 14 (77.8) 13 (76.5)  
  • Colonic perforation 15 (16.7) 7 (12.7) 4 (22.2) 4 (23.5)  
 Surgical approach [n (%)]      
  • Laparoscopy 17 (18.9) 6 (10.9) 6 (33.3) 5 (29.4) 0.051
  • Open surgery 73 (81.1) 49 (89.1) 12 (66.7) 12 (70.6)  
 Previous abdominal surgery [n (%)]      
  • Laparoscopy 6 (6.7) 4 (7.3) 0 2 (11.8) 0.363
  • Open surgery 20 (22.2) 11 (20) 3 (16.7) 6 (35.3) 0.340
 One- or two-stage surgery [n (%)]      0.236
  • One-stage surgery with primary anastomosis 70 (77.8) 46 (83.6) 12 (66.7) 12 (70.6)  
  • Two-step procedure by temporary ostomy 20 (22.2) 9 (16.4) 6 (33.3) 5 (29.4)  
 Simultaneous splenectomy [n (%)] 8 (8.9) 5 (9.1) 3 (16.7) 0 0.222
Preoperative imaging assessment on CT-scan
 Tumor size (largest dimension, cm) [mean (SD)] 4.44 (2.01) 4.24 (1.67) 5.55 (2.92) 3.93 (1.46) 0.070
 Peri-colic nodal involvement [n (%)] 40 (44.4) 21 (38.2) 9 (50) 10 (58.8) 0.283
 Patients with suspected extra-colic organs involved [n (%)] 5 (5.6) 0 5 (27.8) 0 < 0.0001
 Suspected synchronous metastasis [n (%)] 16 (17.8) 11 (20) 2 (11.1) 3 (17.6) 0.693
Histological/oncological variables
 Stage of disease AJCC [n (%)]      0.490
  • I 5 (5.6) 5 (9.1) 0 0  
  • II 34 (37.8) 21 (38.2) 8 (44.4) 5 (29.4)  
  • III 40 (44.4) 22 (40) 9 (50) 9 (52.9)  
  • IVa 11 (12.2) 7 (12.7) 1 (5.6) 3 (17.6)  
 Vascular invasion [n (%)] 27 (30) 15 (27.3) 6 (33.3) 6 (35.3) 0.772
 Lymphatic invasion [n (%)] 33 (36.7) 17 (30.9) 8 (44.4) 8 (47.1) 0.360
 Perineural invasion [n (%)] 24 (26.7) 11 (20) 9 (50) 4 (23.5) 0.042
 Tumor size-largest dimension (cm) [mean (SD)] 4.6 (1.73) 4.56 (1.94) 5.19 (1.35) 4.07 (1.19) 0.039
 Tumor grade [n (%)]      0.024
  • Well differentiated 26 (28.9) 21 (38.2) 3 (16.7) 2 (11.8)  
  • Moderately differentiated 48 (53.3) 22 (40) 12 (66.7) 14 (82.4)  
  • Poorly differentiated 16 (17.8) 12 (21.8) 3 (16.7) 1 (5.9)  
 Adjuvant treatment [n (%)] 44 (48.9) 24 (43.6) 11 (61.1) 9 (52.9) 0.408
  1. Significant p values are indicated in bold
  2. AJCC American Joint Committee on Cancer, ASA American Society of Anesthesiology, BMI body mass index, CEA carcinoembryonic antigen, CT computed tomography, ERC extended right colectomy, LC left colectomy, SLC segmental left colectomy, SFC splenic flexure cancer